
Paul E. Zarek
Examiner (ID: 18450)
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1617, 1628, 4161 |
| Total Applications | 773 |
| Issued Applications | 369 |
| Pending Applications | 1 |
| Abandoned Applications | 407 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6517081
[patent_doc_number] => 20100261695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-14
[patent_title] => 'TREATMENT OF ONYCHOMYCOSIS AND RELATED COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/757881
[patent_app_country] => US
[patent_app_date] => 2010-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 984
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20100261695.pdf
[firstpage_image] =>[orig_patent_app_number] => 12757881
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/757881 | TREATMENT OF ONYCHOMYCOSIS AND RELATED COMPOSITIONS | Apr 8, 2010 | Abandoned |
Array
(
[id] => 6497032
[patent_doc_number] => 20100286124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'PROP-2-YN-1-AMINE INHIBITORS OF MONOAMINE OXIDASE TYPE B'
[patent_app_type] => utility
[patent_app_number] => 12/757237
[patent_app_country] => US
[patent_app_date] => 2010-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12035
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20100286124.pdf
[firstpage_image] =>[orig_patent_app_number] => 12757237
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/757237 | PROP-2-YN-1-AMINE INHIBITORS OF MONOAMINE OXIDASE TYPE B | Apr 8, 2010 | Abandoned |
Array
(
[id] => 8591963
[patent_doc_number] => 08349839
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-08
[patent_title] => 'Inhibitors of HIV replication'
[patent_app_type] => utility
[patent_app_number] => 12/756276
[patent_app_country] => US
[patent_app_date] => 2010-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48935
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12756276
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/756276 | Inhibitors of HIV replication | Apr 7, 2010 | Issued |
Array
(
[id] => 6150019
[patent_doc_number] => 20110021614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'USE OF SILYMARIN AND SILYBIN IN THE TREATMENT OF NEURAL INJURY'
[patent_app_type] => utility
[patent_app_number] => 12/754305
[patent_app_country] => US
[patent_app_date] => 2010-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4155
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20110021614.pdf
[firstpage_image] =>[orig_patent_app_number] => 12754305
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/754305 | Use of silymarin and silybin in the treatment of neural injury | Apr 4, 2010 | Issued |
Array
(
[id] => 6128236
[patent_doc_number] => 20110086913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-14
[patent_title] => 'METHODS FOR TREATING MYOFASCIAL, MUSCLE, AND/OR BACK PAIN'
[patent_app_type] => utility
[patent_app_number] => 12/752384
[patent_app_country] => US
[patent_app_date] => 2010-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4070
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20110086913.pdf
[firstpage_image] =>[orig_patent_app_number] => 12752384
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/752384 | METHODS FOR TREATING MYOFASCIAL, MUSCLE, AND/OR BACK PAIN | Mar 31, 2010 | Abandoned |
Array
(
[id] => 8543500
[patent_doc_number] => 08318793
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-27
[patent_title] => 'Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/748875
[patent_app_country] => US
[patent_app_date] => 2010-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20212
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12748875
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/748875 | Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors | Mar 28, 2010 | Issued |
Array
(
[id] => 6568995
[patent_doc_number] => 20100234408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-16
[patent_title] => 'PYRIMIDYLAMINOBENZAMIDE DERIVATIVES FOR THE TREATMENT OF NEUROFIBROMATOSIS'
[patent_app_type] => utility
[patent_app_number] => 12/730590
[patent_app_country] => US
[patent_app_date] => 2010-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5476
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20100234408.pdf
[firstpage_image] =>[orig_patent_app_number] => 12730590
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/730590 | PYRIMIDYLAMINOBENZAMIDE DERIVATIVES FOR THE TREATMENT OF NEUROFIBROMATOSIS | Mar 23, 2010 | Abandoned |
Array
(
[id] => 6424425
[patent_doc_number] => 20100168071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'EXTENDED ESTROGEN DOSING CONTRACEPTIVE REGIMEN'
[patent_app_type] => utility
[patent_app_number] => 12/722967
[patent_app_country] => US
[patent_app_date] => 2010-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2719
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20100168071.pdf
[firstpage_image] =>[orig_patent_app_number] => 12722967
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/722967 | EXTENDED ESTROGEN DOSING CONTRACEPTIVE REGIMEN | Mar 11, 2010 | Abandoned |
Array
(
[id] => 5953991
[patent_doc_number] => 20110034432
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-10
[patent_title] => 'BENZAMIDE DERIVATIVES AND THEIR USE AS GLUCOKINASE ACTIVATING AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/722936
[patent_app_country] => US
[patent_app_date] => 2010-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43575
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20110034432.pdf
[firstpage_image] =>[orig_patent_app_number] => 12722936
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/722936 | BENZAMIDE DERIVATIVES AND THEIR USE AS GLUCOKINASE ACTIVATING AGENTS | Mar 11, 2010 | Abandoned |
Array
(
[id] => 9227545
[patent_doc_number] => 08633212
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-01-21
[patent_title] => 'Inhibitors of beta-secretase'
[patent_app_type] => utility
[patent_app_number] => 12/723137
[patent_app_country] => US
[patent_app_date] => 2010-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 231883
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12723137
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/723137 | Inhibitors of beta-secretase | Mar 11, 2010 | Issued |
Array
(
[id] => 6090467
[patent_doc_number] => 20110218170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-08
[patent_title] => 'USE OF 2\'-DEOXY-4\'-THIOCYTIDINE AND ITS ANALOGUES AS DNA HYPOMETHYLATING ANTICANCER AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/715811
[patent_app_country] => US
[patent_app_date] => 2010-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6178
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0218/20110218170.pdf
[firstpage_image] =>[orig_patent_app_number] => 12715811
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/715811 | USE OF 2'-DEOXY-4'-THIOCYTIDINE AND ITS ANALOGUES AS DNA HYPOMETHYLATING ANTICANCER AGENTS | Mar 1, 2010 | Abandoned |
Array
(
[id] => 9375844
[patent_doc_number] => 08680109
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-25
[patent_title] => 'Combination product comprising SRC kinase inhibitor AZDO530 and an antioestrogen or EGFR-TK-inhibitor'
[patent_app_type] => utility
[patent_app_number] => 12/714997
[patent_app_country] => US
[patent_app_date] => 2010-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14709
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12714997
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/714997 | Combination product comprising SRC kinase inhibitor AZDO530 and an antioestrogen or EGFR-TK-inhibitor | Feb 28, 2010 | Issued |
Array
(
[id] => 7550775
[patent_doc_number] => 08063108
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-22
[patent_title] => 'Method for modulating microbial quorum sensing'
[patent_app_type] => utility
[patent_app_number] => 12/712948
[patent_app_country] => US
[patent_app_date] => 2010-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 22
[patent_no_of_words] => 9993
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/063/08063108.pdf
[firstpage_image] =>[orig_patent_app_number] => 12712948
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/712948 | Method for modulating microbial quorum sensing | Feb 24, 2010 | Issued |
Array
(
[id] => 6444215
[patent_doc_number] => 20100144639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'USE OF INHIBITORS OF THE EGFR-MEDIATED SIGNAL TRANSDUCTION FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH) / PROSTATIC HYPERTROPHY'
[patent_app_type] => utility
[patent_app_number] => 12/706819
[patent_app_country] => US
[patent_app_date] => 2010-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5743
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20100144639.pdf
[firstpage_image] =>[orig_patent_app_number] => 12706819
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/706819 | Use of inhibitors of the EGFR-mediated signal transduction for the treatment of benign prostatic hyperplasia (BPH)/prostatic hypertrophy | Feb 16, 2010 | Issued |
Array
(
[id] => 6136453
[patent_doc_number] => 20110009378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-13
[patent_title] => 'Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy'
[patent_app_type] => utility
[patent_app_number] => 12/706321
[patent_app_country] => US
[patent_app_date] => 2010-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33527
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20110009378.pdf
[firstpage_image] =>[orig_patent_app_number] => 12706321
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/706321 | Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy | Feb 15, 2010 | Issued |
Array
(
[id] => 9626654
[patent_doc_number] => 08796334
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-05
[patent_title] => 'Methods of treating hair related conditions'
[patent_app_type] => utility
[patent_app_number] => 13/201790
[patent_app_country] => US
[patent_app_date] => 2010-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 15
[patent_no_of_words] => 9454
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13201790
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/201790 | Methods of treating hair related conditions | Feb 15, 2010 | Issued |
Array
(
[id] => 7663785
[patent_doc_number] => 20110313054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'BRANCHED COPOLYMERS, COMPOSITION AND USES'
[patent_app_type] => utility
[patent_app_number] => 13/148470
[patent_app_country] => US
[patent_app_date] => 2010-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9792
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0313/20110313054.pdf
[firstpage_image] =>[orig_patent_app_number] => 13148470
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/148470 | BRANCHED COPOLYMERS, COMPOSITION AND USES | Feb 8, 2010 | Abandoned |
Array
(
[id] => 6508228
[patent_doc_number] => 20100286585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'Shunt Delivery of Curcumin'
[patent_app_type] => utility
[patent_app_number] => 12/696588
[patent_app_country] => US
[patent_app_date] => 2010-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 6119
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20100286585.pdf
[firstpage_image] =>[orig_patent_app_number] => 12696588
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/696588 | Shunt Delivery of Curcumin | Jan 28, 2010 | Abandoned |
Array
(
[id] => 7561764
[patent_doc_number] => 20110275597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-10
[patent_title] => 'PHARMACEUTICAL COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 13/143808
[patent_app_country] => US
[patent_app_date] => 2010-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5968
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20110275597.pdf
[firstpage_image] =>[orig_patent_app_number] => 13143808
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/143808 | Pharmaceutical composition | Jan 7, 2010 | Issued |
Array
(
[id] => 5993522
[patent_doc_number] => 20110015175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-20
[patent_title] => 'Bicyclic Compounds for the Reduction of Beta-Amyloid Production'
[patent_app_type] => utility
[patent_app_number] => 12/683791
[patent_app_country] => US
[patent_app_date] => 2010-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 77938
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20110015175.pdf
[firstpage_image] =>[orig_patent_app_number] => 12683791
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/683791 | Bicyclic compounds for the reduction of beta-amyloid production | Jan 6, 2010 | Issued |